Basma Adeem Medical company (TADAWUL:9626)

TADAWUL:9626 Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	33.92	26.52	21.92
Revenue Growth (YoY)	27.88%	20.99%	-
Cost of Revenue	22.98	18.19	15.02
Gross Profit	10.94	8.33	6.9
Selling, General & Admin	3.14	2.48	2.57
Operating Expenses	3.41	2.74	2.69
Operating Income	7.52	5.59	4.21
Interest Expense	-0.34	-0.36	-0.29
Interest & Investment Income	0.1	-	-
Other Non Operating Income (Expenses)	-0.5	-0.3	-
EBT Excluding Unusual Items	6.78	4.93	3.92
Other Unusual Items	-0	0.13	-
Pretax Income	6.78	5.06	3.92
Income Tax Expense	0.48	0.19	0.14
Net Income	6.3	4.87	3.78
Net Income to Common	6.3	4.87	3.78
Net Income Growth	29.40%	28.71%	-
Shares Outstanding (Basic)	12	10	-
Shares Outstanding (Diluted)	12	10	-
Shares Change (YoY)	21.59%	-	-
EPS (Basic)	0.55	0.51	-
EPS (Diluted)	0.55	0.51	-
EPS Growth	6.42%	-	-
Free Cash Flow	6.66	4.07	5.24
Free Cash Flow Per Share	0.58	0.43	-
Gross Margin	32.25%	31.41%	31.46%
Operating Margin	22.18%	21.07%	19.20%
Profit Margin	18.58%	18.36%	17.26%
Free Cash Flow Margin	19.64%	15.34%	23.90%
EBITDA	8.15	6.2	4.54
EBITDA Margin	24.02%	23.36%	20.71%
D&A For EBITDA	0.62	0.61	0.33
EBIT	7.52	5.59	4.21
EBIT Margin	22.18%	21.07%	19.20%
Effective Tax Rate	7.11%	3.69%	3.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.